HMGBiotech has joined CICON 2023 through a poster presentation by Dr. Liam Colley.
CICON is the international reference meeting for scientists, clinicians, regulators, drug developers, and patient advocates.
Liam Colley, HMGBiotech’s researcher, gave a speech about “The role of CXCR4 in Triggering Immunosurveillance in the Malignant Mesothelioma Tumor Environment”. During the speech has been highlighted how CXCR4 acts as a hub for anti-tumor immune signaling on malignant mesothelioma cells. CXCR4 is the receptor of CXCL12 chemokine protein: theese proteins create an axis which plays a relevant role in shaping the tumor microenvironment (TME), mainly against dampening immune responses.
The conclusions of the studies about the role of CXCR4 might be exploited to improve current immunotherapies.
HMGBiotech can provide all the information to help you make an informed decision for your research purposes.
Discover our HMGB1 proteins and request a quotation
